On February 22, the Ajmera Transplant Centre and the Centre for Living Organ Donation at UHN hosted the first COVID-19 Vaccine Q&A to address questions about vaccine safety and efficacy in transplant recipients and the concerns of the wider transplant community.

 

Thank you to our sponsor, Astellas Pharma Canada Inc., and thank you to the Toronto General and Western Hospital Foundation for their continued support. 

 

 

Dr Deepali Kumar, Transplant Infectious Diseases Specialist, Ajmera Transplant Centre, UHN answers five questions that are top of mind for every transplant recipient.

Dr. Sunita Singh, Medical Director of the Live Donor Kidney Transplant Program, guides viewers through the living kidney donor assessment process. Following Dr. Singh, Jane Garratt, living kidney donor, shares her story. 

Dr. York Pei gives an in depth presentation on polycystic kidney disease, including diagnosis and treatment options. Following Dr. Pei, patient partners Janet Wright and Claudia Morgan, both living donor kidney transplant recipients, share their stories. 

On March 4, Dr. Natasha Chandok, Associate Director of the Osler Hepatitis Centre, will explain the etiologies, epidemiology and treatments of common liver diseases. Dr. Chandok will also review the importance of improving liver health and access to liver care - including transplantation for liver failure - in the South Asian community. Transplant social worker, Sonali Pendharkar, will discuss challenges and supports available for patients pre- and post-transplant, and help address audience questions during the Q&A portion of the webinar.

Dr. Aliya Gulamhusein presents on PBC symptoms, diagnosis and treatment options

An overview and Q&A presented by Dr. Sunita Singh, Medical Director of the Live Donor Kidney Transplant Program, UHN.